The Cooper Cos., Inc. (COO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 06, 2025

$93.01

P/E Ratio

47.51

Market Cap

$18.56B

Jan 18, 2024Feb 22, 2024Mar 27, 2024May 1, 2024Jun 4, 2024Jul 8, 2024Aug 7, 2024Sep 11, 2024Oct 16, 2024Nov 20, 2024Jan 6, 2025$10.00$20.00$30.00
  • XP
Description

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Metrics

Overview

  • HQSan Ramon, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerCOO
  • Price$93.01+1.33%

Trading Information

  • Market cap$18.56B
  • Float99.50%
  • Average Daily Volume (1m)1,326,720
  • Average Daily Volume (3m)1,316,689
  • EPS$1.97

Company

  • Revenue$3.90B
  • Rev growth (1yr)8.41%
  • Net income$392.30M
  • Gross margin61.47%
  • EBITDA margin28.74%
  • EBITDA$1.12B
  • EV$23.72B
  • EV/Revenue6.09
  • P/E47.51
  • P/S4.78
  • P/B2.30
Documents